| Treatment of acromegaly with the growth hormone–receptor antagonist pegvisomant PJ Trainer, WM Drake, L Katznelson, PU Freda, V Herman-Bonert, ... New England Journal of Medicine 342 (16), 1171-1177, 2000 | 1023 | 2000 |
| Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth … PE Clayton, S Cianfarani, P Czernichow, G Johannsson, R Rapaport, ... The Journal of Clinical Endocrinology & Metabolism 92 (3), 804-810, 2007 | 927 | 2007 |
| Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist AJ Van Der Lely, RK Hutson, PJ Trainer, GM Besser, AL Barkan, ... The Lancet 358 (9295), 1754-1759, 2001 | 788 | 2001 |
| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 613 | 2019 |
| Premature mortality in patients with Addison’s disease: a population-based study R Bergthorsdottir, M Leonsson-Zachrisson, A Odén, G Johannsson The Journal of Clinical Endocrinology & Metabolism 91 (12), 4849-4853, 2006 | 588 | 2006 |
| Estrogen regulation of growth hormone action KC Leung, G Johannsson, GM Leong, KKY Ho Endocrine reviews 25 (5), 693-721, 2004 | 585 | 2004 |
| Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure G Johannsson, P Mårin, L Lönn, M Ottosson, K Stenlöf, P Björntorp, ... The Journal of Clinical Endocrinology & Metabolism 82 (3), 727-734, 1997 | 584 | 1997 |
| Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for … KKY Ho European journal of endocrinology 157 (6), 695-700, 2007 | 536 | 2007 |
| Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation G Johannsson, AG Nilsson, R Bergthorsdottir, P Burman, P Dahlqvist, ... The Journal of Clinical Endocrinology & Metabolism 97 (2), 473-481, 2012 | 367 | 2012 |
| Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome CL Deal, M Tony, C Höybye, DB Allen, M Tauber, JS Christiansen, ... The Journal of Clinical Endocrinology & Metabolism 98 (6), E1072-E1087, 2013 | 352 | 2013 |
| The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients H Filipsson, JP Monson, M Koltowska-Häggström, A Mattsson, ... The Journal of Clinical Endocrinology & Metabolism 91 (10), 3954-3961, 2006 | 351 | 2006 |
| Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models DE Berryman, JS Christiansen, G Johannsson, MO Thorner, JJ Kopchick Growth Hormone & IGF Research 18 (6), 455-471, 2008 | 330 | 2008 |
| Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency G Johannsson, T Rosen, I Bosaeus, L Sjöström, BÅ Bengtsson The Journal of Clinical Endocrinology & Metabolism 81 (8), 2865-2873, 1996 | 292 | 1996 |
| A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices G Gotherstrom, J Svensson, J Koranyi, M Alpsten, I Bosaeus, ... The Journal of Clinical Endocrinology & Metabolism 86 (10), 4657-4665, 2001 | 278 | 2001 |
| Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy J Svensson, BA Bengtsson, T Rosen, A Oden, G Johannsson The Journal of Clinical Endocrinology & Metabolism 89 (7), 3306-3312, 2004 | 271 | 2004 |
| Hypopituitarism CE Higham, G Johannsson, SM Shalet The Lancet 388 (10058), 2403-2415, 2016 | 264 | 2016 |
| Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial G Johannsson, P Burman, L Wirén, BE Engström, AG Nilsson, ... The Journal of Clinical Endocrinology & Metabolism 87 (5), 2046-2052, 2002 | 244 | 2002 |
| GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults DB Allen, P Backeljauw, M Bidlingmaier, BMK Biller, M Boguszewski, ... European Journal of Endocrinology 174 (2), P1-P9, 2016 | 239 | 2016 |
| The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations DE Berryman, CAM Glad, EO List, G Johannsson Nature Reviews Endocrinology 9 (6), 346-356, 2013 | 239 | 2013 |
| The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. G Johannsson, R Bjarnason, M Bramnert, LM Carlsson, M Degerblad, ... The Journal of Clinical Endocrinology & Metabolism 81 (4), 1575-1581, 1996 | 233 | 1996 |
Daniel S OlssonSahlgrenska University HospitalVerified email at gu.se
